NCT03839693View on ClinicalTrials.gov

ET-01 in Subjects With Lateral Canthal Lines, LCL-208

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 16, 2018

Primary Completion Date

April 18, 2019

Study Completion Date

September 19, 2019

Conditions
Lateral Canthal LinesCrow's Feet
Interventions
BIOLOGICAL

botulinum toxin, Type A

topical liniment

BIOLOGICAL

Vehicle

Vehicle Formulation

Trial Locations (5)

23502

Virginia Clinical Research, Inc., Norfolk

33137

Baumann Cosmetic & Research Institute, Miami

33781

Synexus, Inc., Pinellas Park

40202

Forefront Dermatology, Louisville

78746

Westlake Dermatology Clinical Research Center, Austin

Sponsors
All Listed Sponsors
lead

Eirion Therapeutics Inc.

INDUSTRY